{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T04:52:47Z","timestamp":1648961567204},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.tripleo.2007.12.003","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T15:30:22Z","timestamp":1205335822000},"page":"457-459","source":"Crossref","is-referenced-by-count":4,"title":["Antifungal susceptibility testing of micafungin against Candida glabrata isolates"],"prefix":"10.1016","volume":"105","author":[{"given":"Erica R.","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Fothergill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spencer W.","family":"Redding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tripleo.2007.12.003_bib1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s10096-003-0973-8","article-title":"Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis","volume":"22","author":"Colombo","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.tripleo.2007.12.003_bib2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2007.12.003_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tripleo.2007.12.003_bib4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/AAC.44.3.747-751.2000","article-title":"Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998","volume":"44","author":"Pfaller","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2007.12.003_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/315193","article-title":"Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole","volume":"181","author":"Marr","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tripleo.2007.12.003_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0002-9343(95)00010-0","article-title":"The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance","volume":"100","author":"Nguyen","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.tripleo.2007.12.003_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dki218","article-title":"Changing patterns and trends in systemic fungal infections","volume":"56","author":"Richardson","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tripleo.2007.12.003_bib8","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","author":"Denning","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.tripleo.2007.12.003_bib9","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1345\/aph.1D301","article-title":"New drug developments: Micafungin","volume":"38","author":"Carver","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.tripleo.2007.12.003_bib10","series-title":"Comparison of micafungin and caspofungin for candidemia or invasive candidiasis","author":"Betts","year":"2006"},{"key":"10.1016\/j.tripleo.2007.12.003_bib11","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1128\/AAC.47.10.3149-3154.2003","article-title":"Antifungal susceptibility survey of 2,000 blood-stream Candida isolates in the United States","volume":"47","author":"Ostrosky-Zeichner","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2007.12.003_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/AAC.44.1.57-62.2000","article-title":"In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi","volume":"44","author":"Tawara","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2007.12.003_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/jac\/46.3.485","article-title":"In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide","volume":"46","author":"Mikamo","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tripleo.2007.12.003_bib14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jac\/44.5.697","article-title":"In vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp","volume":"44","author":"Chavez","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tripleo.2007.12.003_bib15","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1128\/AAC.46.12.3846-3853.2002","article-title":"Ivitro activity of micafungin (FK-463) against Candida spp.: microdilution, time kill, and post-antifungal effect studies","volume":"46","author":"Ernst","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tripleo.2007.12.003_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jac\/dkf074","article-title":"In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients","volume":"50","author":"Laverdiere","year":"2002","journal-title":"J Antimicrob Chemother"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210407009158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210407009158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T22:30:13Z","timestamp":1546209013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210407009158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1079210407009158"],"URL":"https:\/\/doi.org\/10.1016\/j.tripleo.2007.12.003","relation":{},"ISSN":["1079-2104"],"issn-type":[{"value":"1079-2104","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}